Neal Gilmer is maintaining his “Buy” rating and C$21.00 target price, citing strong margins, robust cash flow and continued ...

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and C$11.00 price target in a May 8 note.

Knight Therapeutics is continuing to build momentum, according to Stifel Nicolaus Canada analyst Justin Keywood.

Roth Capital Partners has raised its price target on Groupon ( Groupon Inc Stock Quote, Chart, News, Analysts, Financials ...

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings ( Verano Holdings Stock Quote, Chart, News, Analysts, ...

Xtract One Technologies may be nearing a significant financial milestone, with Ventum Capital calling the security tech firm ...

5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

Ballard Power’s disappointing Q1 2025 results prompted Roth Capital Partners analyst Craig Irwin to reaffirm his $1.25 price ...

Ahead of the company’s first quarter results, National Bank Financial analyst Cameron Doerksen has upgraded CAE.

Spectral is a clinical-stage medical device company focused on developing therapies for critical care, particularly septic ...

ATB Capital Markets is sticking with its bullish view on Bitfarms, maintaining an Outperform rating and a $3.75 price target ...

In a May 5 investor note, Leede Financial analyst Douglas Loe reiterated his Speculative Buy rating and $3.00 target for ...